Structure Therapeutics, Inc. (GPCR)
21.87
-0.07
(-0.32%)
USD |
NASDAQ |
Oct 30, 16:00
22.41
+0.54
(+2.47%)
Pre-Market: 20:00
Structure Therapeutics 30-Day Average Daily Volume : 1.298M for Oct. 30, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 30, 2026 | 1.298M |
| October 29, 2026 | 1.326M |
| October 28, 2026 | 1.335M |
| October 27, 2026 | 1.357M |
| October 26, 2026 | 1.381M |
| October 23, 2026 | 1.408M |
| October 22, 2026 | 1.424M |
| October 21, 2026 | 1.426M |
| October 20, 2026 | 1.451M |
| October 19, 2026 | 1.518M |
| October 16, 2026 | 1.484M |
| October 15, 2026 | 1.466M |
| October 14, 2026 | 1.454M |
| October 13, 2026 | 1.413M |
| October 12, 2026 | 1.411M |
| October 09, 2026 | 1.376M |
| October 08, 2026 | 1.366M |
| October 07, 2026 | 1.366M |
| October 06, 2026 | 1.347M |
| October 05, 2026 | 1.327M |
| October 02, 2026 | 1.284M |
| October 01, 2026 | 1.275M |
| September 30, 2026 | 1.212M |
| September 29, 2026 | 1.162M |
| September 28, 2026 | 1.114M |
| Date | Value |
|---|---|
| September 25, 2026 | 1.090M |
| September 24, 2026 | 1.052M |
| September 23, 2026 | 1.032M |
| September 22, 2026 | 1.001M |
| September 21, 2026 | 992451.4 |
| September 18, 2026 | 969374.0 |
| September 17, 2026 | 928956.5 |
| September 16, 2026 | 913427.4 |
| September 15, 2026 | 887682.0 |
| September 14, 2026 | 849539.6 |
| September 11, 2026 | 813180.9 |
| September 10, 2026 | 783438.0 |
| September 09, 2026 | 773735.0 |
| September 08, 2026 | 738576.3 |
| September 04, 2026 | 640134.8 |
| September 03, 2026 | 652591.4 |
| September 02, 2026 | 654054.1 |
| September 01, 2026 | 639122.9 |
| August 31, 2026 | 621878.6 |
| August 28, 2026 | 588941.6 |
| August 27, 2026 | 599389.2 |
| August 26, 2026 | 610566.0 |
| August 25, 2026 | 602143.3 |
| August 24, 2026 | 605542.7 |
| August 21, 2026 | 594500.8 |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Eli Lilly & Co. | 2.448M |
| Novo Nordisk A/S | 13.38M |
| Pfizer Inc. | 30.18M |
| Viking Therapeutics, Inc. | 8.120M |
| Liquidia Corp. | 5.568M |